These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21762646)

  • 21. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
    Williams W; Bhagwandass A; Sargeant LA; Shah D
    Lupus; 2003; 12(8):640-5. PubMed ID: 12945726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial.
    Gheet FS; Dawoud HE; El-Shahaby WA; Elrifaey SM; Abdelnabi HH
    Eur J Pediatr; 2023 Apr; 182(4):1685-1695. PubMed ID: 36752895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
    Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
    Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cyclophosphamide and other immunosuppressive drugs in the treatment of patients with lupus nephritis.
    Brugos B; Sebestyen L; Tarr T; Vincze Z
    Pharmazie; 2014 Jun; 69(6):442-4. PubMed ID: 24974578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of patients with lupus nephritis under long-term immunonephrological care].
    Polner K; Arányi J; Braunitzer H; Kaszás I; Haris Á
    Orv Hetil; 2020 Aug; 161(31):1293-1301. PubMed ID: 32750018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse proliferative crescentic lupus nephritis with normal renal function.
    Gupta V; Sachdeva S; Khan AS; Haque SF
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):343-5. PubMed ID: 22382232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
    Hsieh YP; Wen YK; Chen ML
    Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
    Kasitanon N; Boripatkosol P; Louthrenoo W
    Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease severity of proliferative lupus nephritis in Maghrebians.
    Tamirou F; Costedoat-Chalumeau N; Medkouri G; Daugas E; Hachulla E; Jourde-Chiche N; Karras A; le Guern V; Gnemmi V; Jadoul M; Houssiau FA
    Lupus; 2018 Jul; 27(8):1387-1392. PubMed ID: 29703123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
    Touma Z; Urowitz MB; Ibañez D; Gladman DD
    J Rheumatol; 2014 Apr; 41(4):688-97. PubMed ID: 24429170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
    Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
    Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of lupus nephritis with cyclosporin A.
    Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
    QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of membranous lupus nephritis: where are we now?
    Beck LH; Salant DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.